Oligodendroglioma Global Clinical Trials Review, H1, 2012
GlobalData
January 27, 2012 91 Pages - SKU: GBDT6797454
|
|
Oligodendroglioma Global Clinical Trials Review, H1, 2012
Summary
GlobalData's clinical trial report, “Oligodendroglioma Global Clinical Trials Review, H1, 2012 provides data on the Oligodendroglioma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Oligodendroglioma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Oligodendroglioma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
|
- Introduction
- Oligodendroglioma
- Report Guidance
- Clinical Trials by Region
- Clinical Trials by Country
- Top Countries Contributing to Clinical Trials in Asia-Pacific
- Top Five Countries Contributing to Clinical Trials in Europe
- Top Countries Contributing to Clinical Trials in North America
- Clinical Trials by BRIC Nations
- Clinical Trials by G7 Nations
- Clinical Trials in G7 Nations by Trial Status
- Clinical Trials by E7 Nations
- Clinical Trials in E7 Nations by Trial Status
- Clinical Trials by Phase
- In Progress Trials by Phase
- Clinical Trials by Trial Status
- Unaccomplished Trials of Oligodendroglioma
- Subjects Recruited Over a Period of Time
- Prominent Sponsors
- Top Companies Participating in Oligodendroglioma Therapeutics Clinical Trials
- Prominent Drug Comparison
- Clinical Trial Profiles
- Clinical Trial Overview of Top Companies
- Tocagen Inc.
- Clinical Trial Overview of Tocagen Inc.
- TransMolecular, Inc.
- Clinical Trial Overview of TransMolecular, Inc.
- AOI Pharmaceuticals, Incorporated
- Clinical Trial Overview of AOI Pharmaceuticals, Incorporated
- INSYS Therapeutics, Inc.
- Clinical Trial Overview of INSYS Therapeutics, Inc.
- Teva Pharmaceuticals USA, Inc.
- Clinical Trial Overview of Teva Pharmaceuticals USA, Inc.
- Pharmacyclics, Inc.
- Clinical Trial Overview of Pharmacyclics, Inc.
- Clinical Trial Overview of Top Universities / Institutes / Hospitals
- City of Hope National Medical Center
- Clinical Trial Overview of City of Hope National Medical Center
- Case Comprehensive Cancer Center
- Clinical Trial Overview of Case Comprehensive Cancer Center
- Dana-Farber Cancer Institute
- Clinical Trial Overview of Dana-Farber Cancer Institute
- Wake Forest University
- Clinical Trial Overview of Wake Forest University
- University of California, San Francisco
- Clinical Trial Overview of University of California, San Francisco
- University of Pittsburgh
- Clinical Trial Overview of University of Pittsburgh
- Ohio State University Comprehensive Cancer Center
- Clinical Trial Overview of Ohio State University Comprehensive Cancer Center
- Les Hopitaux Universitaires de Strasbourg
- Clinical Trial Overview of Les Hopitaux Universitaires de Strasbourg
- European Organization for Research and Treatment of Cancer
- Clinical Trial Overview of European Organization for Research and Treatment of Cancer
- Abramson Cancer Center
- Clinical Trial Overview of Abramson Cancer Center
- Memorial Sloan Kettering Cancer Center
- Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
- Ludwig-Maximilians-Universitat Munich
- Clinical Trial Overview of Ludwig-Maximilians-Universitat Munich
- Northwestern University
- Clinical Trial Overview of Northwestern University
- University of California, Los Angeles
- Clinical Trial Overview of University of California, Los Angeles
- Sun Yat-sen University
- Clinical Trial Overview of Sun Yat-sen University
- Radiation Therapy Oncology Group
- Clinical Trial Overview of Radiation Therapy Oncology Group
- Roswell Park Cancer Institute
- Clinical Trial Overview of Roswell Park Cancer Institute
- Weill Cornell Medical College
- Clinical Trial Overview of Weill Cornell Medical College
- Hopitaux Universitaires de Geneve
- Clinical Trial Overview of Hopitaux Universitaires de Geneve
- H. Lee Moffitt Cancer Center & Research Institute
- Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute
- Five Key Clinical Profiles
- Appendix
- Abbreviations
- Definitions
- Research Methodology
- Secondary Research
- About GlobalData
- Contact Us
- Disclaimer
- Source
- List of Tables
- Oligodendroglioma Therapeutics Market, Global, Clinical Trials by Zone, 2012*
- Oligodendroglioma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
- Oligodendroglioma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
- Oligodendroglioma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012*
- Oligodendroglioma Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
- Oligodendroglioma Therapeutics Clinical Trials, North America, Top Countries, 2012*
- Oligodendroglioma Therapeutics Clinical Trials, BRIC Countries, 2012*
- Oligodendroglioma Therapeutics Clinical Trials, G7 Countries, 2012*
- Oligodendroglioma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
- Oligodendroglioma Therapeutics Clinical Trials, E7 Countries, 2012*
- Oligodendroglioma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
- Oligodendroglioma Therapeutics Market, Global, Clinical Trials by Phase, 2012*
- Oligodendroglioma Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
- Oligodendroglioma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
- Oligodendroglioma Therapeutics Market, Global, Withdrawn Clinical Trials, 2012*
- Oligodendroglioma Therapeutics Market, Global, Terminated Clinical Trials, 2012*
- Oligodendroglioma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
- Oligodendroglioma Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
- Oligodendroglioma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
- Oligodendroglioma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
- Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Tocagen Inc., 2012*
- Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by TransMolecular, Inc., 2012*
- Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by AOI Pharmaceuticals, Incorporated, 2012*
- Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by INSYS Therapeutics, Inc., 2012*
- Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceuticals USA, Inc., 2012*
- Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmacyclics, Inc., 2012*
- Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2012*
- Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012*
- Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012*
- Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2012*
- Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2012*
- Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2012*
- Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Ohio State University Comprehensive Cancer Center, 2012*
- Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Les Hopitaux Universitaires de Strasbourg, 2012*
- Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2012*
- Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Abramson Cancer Center, 2012*
- Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012*
- Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Ludwig-Maximilians-Universitat Munich, 2012*
- Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012*
- Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2012*
- Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2012*
- Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Radiation Therapy Oncology Group, 2012*
- Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2012*
- Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2012*
- Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Hopitaux Universitaires de Geneve, 2012*
- Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lee Moffitt Cancer Center & Research Institute, 2012*
- List of Figures
- Oligodendroglioma Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
- Oligodendroglioma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
- Oligodendroglioma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
- Oligodendroglioma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012*
- Oligodendroglioma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
- Oligodendroglioma Therapeutics Clinical Trials, G7 Countries (%), 2012*
- Oligodendroglioma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
- Oligodendroglioma Therapeutics Clinical Trials, E7 Countries (%), 2012*
- Oligodendroglioma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
- Oligodendroglioma Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
- Oligodendroglioma Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
- Oligodendroglioma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
- Oligodendroglioma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
- Oligodendroglioma Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
- Oligodendroglioma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
- Oligodendroglioma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
- GlobalData Methodology
Share this report
Other tasks Related Markets Drug Discovery Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
